AI is increasingly playing a crucial role in healthcare, with applications such as transcribing patient visits and analyzing medical images. While AI has the potential to revolutionize drug discovery and enhance patient-doctor interactions, there are concerns about bias and the denial of care to those in need. To address these concerns, experts advise caution when using AI tools for diagnosis.
Brian Anderson leads the Coalition for Health in AI (CHAI), a nonprofit organization focused on developing guidelines and standards for responsible use of AI in healthcare. Comprised of academic and industry partners, CHAI aims to establish quality assurance labs to ensure the safety of AI healthcare products. Their goal is to build trust in AI and facilitate informed discussions between patients and healthcare providers about the use of algorithms in medicine. Recently, CHAI released its “Draft Responsible Health AI Framework” for public feedback.
Some critics question whether CHAI, with members from tech giants like Microsoft and Google, can effectively regulate the AI industry on its own. Others suggest alternative, more localized regulatory frameworks for AI in healthcare. Despite these challenges, CHAI remains committed to promoting responsible use of AI in healthcare and ensuring that patients receive safe, effective care.
